Benchmark and data visualization of Swedish public listed companies in the Drug Manufacturers—Specialty & Generic Industry, with top companies, stocks performance comparison, competitive analysis, and comparisons of top companies for market research.
Sweden public listed companies in the Drug Manufacturers—Specialty & Generic industry: 11
Sweden Drug Manufacturers—Specialty & Generic total companies market cap (USD): $13.86 Billion
Company | Market Cap (USD) | Country | Sector | Industry |
---|---|---|---|---|
Swedish Orphan Biovitrum AB | $8.73 B | Sweden | Healthcare | Drug Manufacturers—Specialty & Generic |
Karo Pharma AB |
$1.49 B
(Nov. 1, 2022) |
Sweden | Healthcare | Drug Manufacturers—Specialty & Generic |
BioGaia AB | $1.18 B | Sweden | Healthcare | Drug Manufacturers—Specialty & Generic |
Calliditas Therapeutics AB (publ) | $1.05 B | Sweden | Healthcare | Drug Manufacturers—Specialty & Generic |
Swedencare AB |
$694.0 M
(Jan. 1, 2025) |
Sweden | Healthcare | Drug Manufacturers—Specialty & Generic |
Probi AB | $311.3 M | Sweden | Healthcare | Drug Manufacturers—Specialty & Generic |
EQL Pharma AB |
$214.1 M
(Jan. 1, 2025) |
Sweden | Healthcare | Drug Manufacturers—Specialty & Generic |
Oasmia Pharmaceutical AB |
$76.7 M
(June 1, 2022) |
Sweden | Healthcare | Drug Manufacturers—Specialty & Generic |
Orexo AB | $66.0 M | Sweden | Healthcare | Drug Manufacturers—Specialty & Generic |
Enzymatica AB | $40.5 M | Sweden | Healthcare | Drug Manufacturers—Specialty & Generic |
Top 1-year algo backtest: +327.04% - Try Disfold DeepFinance for FREE now!